Skip to content

CARDIFF ONCOLOGY, INC.: 10-Q filed 2013-08-14

What CARDIFF ONCOLOGY, INC. reported in its quarterly report filed 2013-08-14 (fiscal Q2 2013): 26 published measures, 98 facts as tagged in accession 0001104659-13-063996.

This filing

Form
10-Q (quarterly report)
Filed
2013-08-14
Fiscal period
fiscal Q2 2013
Accession
0001104659-13-063996 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CARDIFF ONCOLOGY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-309,625,066USD
At 2012-12-3111,665,026USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-06-3012,096,201USD
At 2012-12-319,495,998USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-30-2,471,135USD
At 2012-12-312,169,028USD
At 2011-12-31-4,231,268USD
At 2010-12-31-4,995,365USD
At 2009-12-31-3,786,709USD
At 2008-12-31-4,047,807USD
At 2007-12-31-1,645,793USD
At 2007-01-311,129,659USD
At 2006-01-313,480,710USD
At 2005-01-313,190,935USD
At 2004-01-31-1,578,125USD
At 2003-01-31-1,195,104USD
At 2002-01-31-719,395USD
At 2001-01-31-240,359USD
At 2000-01-3127,240USD
At 1999-08-030USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-308,302,290USD
At 2012-12-3110,819,781USD
At 2012-06-309,304,410USD
At 2011-12-31700,374USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-5,270,090USD91
2013-01-01 to 2013-06-30-6,380,787USD181
1999-08-04 to 2013-06-30-59,988,920USD5080
2012-01-01 to 2012-12-31-11,565,961USD366
2012-04-01 to 2012-06-30-3,426,410USD91
2012-01-01 to 2012-06-30-4,589,050USD182
2011-01-01 to 2011-12-31-2,239,212USD365
2010-01-01 to 2010-12-31-5,449,138USD365
2009-01-01 to 2009-12-31-2,483,807USD365
2008-01-01 to 2008-12-31-5,166,240USD366
2007-02-01 to 2007-12-31-4,683,141USD334
2006-02-01 to 2007-01-31-7,134,067USD365
2005-02-01 to 2006-01-31-7,844,326USD365
2004-02-01 to 2005-01-31-5,371,027USD366
2003-02-01 to 2004-01-31-383,021USD365
2002-02-01 to 2003-01-31-481,609USD365
2001-02-01 to 2002-01-31-524,224USD365
2000-02-01 to 2001-01-31-267,599USD366
1999-08-04 to 2000-01-31-14,760USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-06-30360,138USD181
1999-08-04 to 2013-06-30874,521USD5080
2012-01-01 to 2012-06-30140,969USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-06-30-61,598,689USD
At 2012-12-31-55,202,632USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-30570,947USD
At 2012-12-31254,742USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-06-30887,608USD181
1999-08-04 to 2013-06-3012,900,073USD5080
2012-01-01 to 2012-06-30218,650USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2,374,112USD91
2013-01-01 to 2013-06-30-4,763,951USD181
1999-08-04 to 2013-06-30-48,341,738USD5080
2012-04-01 to 2012-06-30-1,245,519USD91
2012-01-01 to 2012-06-30-2,375,735USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-308,523,507USD
At 2012-12-3111,048,203USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-04-01 to 2013-06-30668USD91
2013-01-01 to 2013-06-30668USD181
1999-08-04 to 2013-06-301,326,040USD5080

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-301,462,230USD
At 2012-12-31730,370USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-06-30297,825USD
At 2012-12-31175,679USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-06-3056,501USD
At 2012-12-31168,381USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
1999-08-04 to 2013-06-30500,000USD5080

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3015,729,524shares
At 2012-12-3115,478,177shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-3059,125,903USD
At 2012-12-3157,370,017USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-06-30530,612USD
At 2012-12-31362,081USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-06-301,101,412USD
At 2012-12-31554,691USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-06-30164,716USD
At 2012-12-3160,041USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-5,279,475USD91
2013-01-01 to 2013-06-30-6,396,057USD181
1999-08-04 to 2013-06-30-61,598,689USD5080
2012-04-01 to 2012-06-30-3,435,970USD91
2012-01-01 to 2012-06-30-4,608,170USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-301,479,263USD91
2013-01-01 to 2013-06-303,185,980USD181
1999-08-04 to 2013-06-3029,106,096USD5080
2012-04-01 to 2012-06-30809,868USD91
2012-01-01 to 2012-06-301,636,830USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-06-3043,933USD181
1999-08-04 to 2013-06-30303,574USD5080
2012-01-01 to 2012-06-3013,975USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
1999-08-04 to 2013-06-3032,755,551USD5080
2012-01-01 to 2012-06-3010,946,605USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-111,880USD181
1999-08-04 to 2013-06-3056,502USD5080
2012-01-01 to 2012-06-306,887USD182

Inspect the source

Entity
CARDIFF ONCOLOGY, INC. / CIK 0001213037
Captured
2026-09-20T07:45:48.177Z
SEC response SHA-256
5fefa7380123168da913afadb8db67f9296559e6467fa58ab3879c6c623fb326

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001213037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))